SweetValueLab
Write for us

Viatris Inc. — Financial Statements & Ratios

VTRS
NASDAQHealthcareDrug Manufacturers - Specialty & GenericCIK 0001792044viatris.comAbout VTRS
Last close · Oct 16, 202618.66+0.43 (+2.39%)
Market cap$21.4B

Key indicators

Revenue14.7BTTM+4.5% on a year earlier+3.4% a year, FY2018–FY2025
Fiscal yearFY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025TTMFY2026EFY2027EFY2028E
Growth
11.3B 11.4B+0.9%11.8B+4.0%17.8B+50.7%16.2B−9.0%15.4B−5.1%14.7B−4.5%14.3B−3.0%14.7B+4.5%14.8B 15.0B 15.5B
— 0.9% 4.0% 50.7% -9.0% -5.1% -4.5% -3.0% 4.5% 3.8% 1.7% 3.1%
$0.68 $0.03−95.6%-$1.11−3800.0%-$1.05+5.4%$1.71+262.9%$0.05−97.1%-$0.53−1160.0%-$3.00−466.0%-$0.40 $2.52 $2.69 $2.87
Profitability
35.5% 34.3%−1.2 pt32.1%−2.2 pt31.3%−0.8 pt40.1%+8.8 pt41.8%+1.8 pt38.3%−3.6 pt35.2%−3.1 pt34.9%−1.8 pt· · ·
8.0% 6.3%−1.7 pt-1.8%−8.1 pt-0.2%+1.6 pt10.0%+10.1 pt5.0%−5.0 pt0.1%−4.9 pt-18.7%−18.8 pt-0.6%+17.9 pt· · ·
3.1% 0.1%−3.0 pt-5.7%−5.8 pt-7.1%−1.5 pt12.8%+19.9 pt0.4%−12.5 pt-4.3%−4.7 pt-24.7%−20.3 pt— · · ·
Cash
2.1B 1.6B−23.9%988.8M−37.8%2.6B+158.9%2.5B−0.5%2.4B−4.9%2.0B−18.4%1.9B−2.0%2.0B+11.6%· · ·
18.5% 14.0%−4.6 pt8.4%−5.6 pt14.4%+6.0 pt15.7%+1.3 pt15.7%+0.0 pt13.5%−2.3 pt13.6%+0.1 pt13.3%+0.9 pt· · ·
Balance sheet
516.50M 516.50M+0.0%601.20M+16.4%1.21B+101.1%1.22B+0.7%1.21B−0.9%— — 1.16B−0.8%· · ·

E = analyst consensus (revenue and EPS only). TTM = the twelve months to Jun 30, 2026: the last fiscal year, plus the quarters since, less the same quarters a year earlier. From the 10-K and the 10-Qs since, as accepted by the SEC; the shaded column is the latest period.